|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | |
| A61P 11/00 | |||
| A61K 31/437 | |||
| A61K 31/397 |
| (11) | Patento numeris | 3592742 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18711796.5 |
| Europos patento paraiškos padavimo data | 2018-03-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-01-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/021489 |
| Data | 2018-03-08 |
| (87) | Numeris | WO 2018/165392 |
| Data | 2018-09-13 |
| (30) | Numeris | Data | Šalis |
| 201762469073 P | 2017-03-09 | US |
| (72) |
FATHEREE, Paul R., US
BRANDT, Gary E.L., US
SMITH, Cameron, US
SULLIVAN, Steven D.E., US
VAN ORDEN, Lori Jean, US
KLEINSCHEK, Melanie A., US
CRATER, Glenn D., US
|
| (73) |
Theravance Biopharma R&D IP, LLC,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (54) | JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE |
| JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE |